Log In
Print this Print this

Macugen, pegaptanib (formerly NX1838)

Also known as: EYE001

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionPegylated oligonucleotide aptamer that binds to vascular endothelial growth factor-165 (VEGF-165)
Molecular Target Vascular endothelial growth factor (VEGF) 165
Mechanism of ActionVascular endothelial growth factor (VEGF) inhibitor
Therapeutic ModalityNucleic acid: Aptamer

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today